Atopic dermatitis
Conditions
Interventions
Control group:Placebo + topical glucocorticoid
The experimental group:Bedma Antomint Moisturizing Cream + Topical Corticosteroid
Sponsors
Beijing Childrens Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Age
3 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1. Ages 3 months to 12 years (inclusive of 3 months and 12 years); 2. Adhering to the Hanifin-Rajka AD diagnostic criteria, moderate atopic dermatitis subjects have an IGA score of 3, and the SCORAD score must be between 15 and 40; 3. The subjects and their guardians are willing to strictly follow the investigator's instructions to use the test product throughout the study period and refrain from using other similar products; 4. The guardians of the subjects agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. There are other skin lesions in the study area besides atopic dermatitis; 2. Screening for those who have used systemic glucocorticoids, immunomodulators or immunosuppressants (excluding antihistamines) within 4 weeks before the assessment; 3. Screening for those who have received systemic treatment with JAK inhibitors/biological agents or other similar treatments within 6 months before the assessment; 4. The subjects have undergone general anesthesia surgery in the past month; 5. Screening for children who have participated in other clinical trials within 3 months before the assessment; 6. The eczema lesions of the subjects show exudation or any other signs of infection (such as pus, erosion, exudation, secondary infection, etc.); 7. Children who are known to be allergic to any component of the test product; 8. Children who, in the judgment of the investigator, are not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety;The improvement effect of the test subject on the recurrence of atopic dermatitis in children; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life;Improvement of clinical symptoms;Subjective satisfaction of the tested item; | — |
Countries
China
Contacts
Public ContactMa Lin
Beijing Childrens Hospital,Capital Medical University
Outcome results
None listed